Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Neurol Surg B Skull Base ; 83(4): 359-366, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35903650

ABSTRACT

Introduction Standardized reconstruction protocols for large open anterior skull base defects with dural resection are not well described. Here we report the outcomes and technique of a multilayered reconstructive algorithm utilizing local tissue, dural graft matrix, and microvascular free tissue transfer (MVFTT) for reconstruction of these deformities. Design This study is a retrospective review. Results Eleven patients (82% males) met inclusion criteria, with five (45%) having concurrent orbital exenteration and eight (73%) requiring maxillectomy. All patients required dural resection with or without intracranial tumor resection, with the average dural defect being 36.0 ± 25.9 cm 2 . Dural graft matrices and pericranial flaps were used for primary reconstruction of the dural defects, which were then reinforced with free fascia or muscle overlay by means of MVFTT. Eight (73%) patients underwent anterolateral thigh MVFTT, with the radial forearm, fibula, and vastus lateralis comprising the remainder. Average total surgical time of tumor resection and reconstruction was 14.9 ± 3.8 hours, with median length of hospitalization being 10 days (IQR: 9.5, 14). Continuous cerebrospinal fluid drainage through a lumber drain was utilized in 10 (91%) patients perioperatively, with an average length of indwelling drain of 5 days. Postoperative complications occurred in two (18%) patients who developed asymptomatic pneumocephalus that resolved with high-flow oxygen therapy. Conclusion A standardized multilayered closure technique of dural graft matrix, pericranial flap, and MVFTT overlay in the reconstruction of large open anterior craniofacial dural defects can assist the reconstructive team in approaching these complex deformities and may help prevent postoperative complications.

2.
Mod Pathol ; 35(8): 1045-1054, 2022 08.
Article in English | MEDLINE | ID: mdl-35184149

ABSTRACT

Oropharyngeal squamous cell carcinoma (OPSCC), largely fueled by the human papillomavirus (HPV), has a complex biological and immunologic phenotype. Although HPV/p16 status can be used to stratify OPSCC patients as a function of survival, it remains unclear what drives an improved treatment response in HPV-associated OPSCC and whether targetable biomarkers exist that can inform a precision oncology approach. We analyzed OPSCC patients treated between 2000 and 2016 and correlated locoregional control (LRC), disease-free survival (DFS) and overall survival (OS) with conventional clinical parameters, risk parameters generated using deep-learning algorithms trained to quantify tumor-infiltrating lymphocytes (TILs) (OP-TIL) and multinucleated tumor cells (MuNI) and targeted transcriptomics. P16 was a dominant determinant of LRC, DFS and OS, but tobacco exposure, OP-TIL and MuNI risk features correlated with clinical outcomes independent of p16 status and the combination of p16, OP-TIL and MuNI generated a better stratification of OPSCC risk compared to individual parameters. Differential gene expression (DEG) analysis demonstrated overlap between MuNI and OP-TIL and identified genes involved in DNA repair, oxidative stress response and tumor immunity as the most prominent correlates with survival. Alteration of inflammatory/immune pathways correlated strongly with all risk features and oncologic outcomes. This suggests that development of OPSCC consists of an intersection between multiple required and permissive oncogenic and immunologic events which may be mechanistically linked. The strong relationship between tumor immunity and oncologic outcomes in OPSCC regardless of HPV status may provide opportunities for further biomarker development and precision oncology approaches incorporating immune checkpoint inhibitors for maximal anti-tumor efficacy.


Subject(s)
Head and Neck Neoplasms , Oropharyngeal Neoplasms , Papillomavirus Infections , Cyclin-Dependent Kinase Inhibitor p16/analysis , Humans , Oropharyngeal Neoplasms/pathology , Papillomaviridae , Papillomavirus Infections/pathology , Precision Medicine , Prognosis , Squamous Cell Carcinoma of Head and Neck
3.
Otolaryngol Head Neck Surg ; 162(6): 888-896, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32093532

ABSTRACT

OBJECTIVE: Advanced laryngeal squamous cell carcinoma remains associated with approximately 50% mortality at 5 years. Delivery of multimodality treatment remains critical to maximizing survival for this disease, but achieving this at a national level remains a difficult undertaking, particularly in under- and uninsured patients as well as minority patients. We sought to evaluate laryngeal cancer treatment delivery and clinical outcomes in a predominantly minority and underserved cohort of largely under- and uninsured patients in a county hospital. STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary care county hospital in Houston, Texas. SUBJECTS AND METHODS: Patients (N = 210) with a new diagnosis of laryngeal squamous cell carcinoma treated between 2005 and 2015 were included in a retrospective analysis of patient demographics, tumor and treatment characteristics, and oncologic outcomes. RESULTS: The majority of patients presented with advanced disease (T4 = 43%, N>0 = 45%). Treatment selection was compliant with National Comprehensive Cancer Network guidelines in 81% of cases, but 76% of patients who required adjuvant radiotherapy were unable to start it within 6 weeks postsurgery. Overall survival and disease-free survival were 52% and 63% for the entire cohort, respectively. Supraglottic subsite and nodal metastases were significantly associated with decreased overall survival and disease-free survival. Race/ethnicity and insurance status were not associated with worse oncologic outcomes. CONCLUSION: Under- and uninsured patients often present with advanced laryngeal cancer. Oncologic outcomes in this cohort of patients is similar to that of other published series. Moreover, tumor characteristics rather than demographic variables drive oncologic outcomes for the predominantly minority and underserved patients seeking care in our tertiary care county hospital.


Subject(s)
Carcinoma, Squamous Cell/epidemiology , Laryngeal Neoplasms/epidemiology , Minority Groups , Neoplasm Staging , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Disease-Free Survival , Follow-Up Studies , Humans , Laryngeal Neoplasms/diagnosis , Laryngeal Neoplasms/therapy , Middle Aged , Retrospective Studies , Survival Rate/trends , Texas/epidemiology
4.
Laryngoscope ; 130(7): 1733-1739, 2020 07.
Article in English | MEDLINE | ID: mdl-31461171

ABSTRACT

OBJECTIVES: Multiple population studies have shown racial discrepancies in head and neck cancer treatment and outcomes. We sought to characterize the impact of race on clinical outcomes for patients with early glottic squamous cell carcinoma (SCC) in a tertiary institution which provides equivalent access to care. METHODS: We retrospectively reviewed all early glottic (T1-T2) squamous cell carcinoma at a single institution, the Michael E. DeBakey Veterans' Administration Medical Center (MEDVAMC). Data collected included demographic information, primary and adjuvant treatment modalities, time to diagnosis, time to treatment, recurrences, recurrence treatment modality, secondary malignancies, recurrence-free survival (RFS), and overall survival (OS). RESULTS: One hundred seventeen patients with a primary diagnosis of T1-T2 glottic squamous cell carcinoma were included. Black and white patients demonstrated equivalent rates of recurrence, RFS, and OS. There was no significant difference in treatment delivery by race for all recorded parameters. T1b tumors were associated with an increased risk of recurrence which did not translate into a statistically significant decrease in RFS or OS. Surgical treatment was associated with increased recurrence but similar RFS and OS compared to radiation-based treatment. Secondary malignancies were common; 12% of patients were diagnosed with a second primary lung cancer during the study period. CONCLUSION: At our institution, race did not impact survival when access to care, treatment selection, and delivery are equivalent for early glottic SCC. Secondary lung cancer is a critical risk factor for mortality in this patient group and requires long-term surveillance and monitoring. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:1733-1739, 2020.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Disease Management , Laryngeal Neoplasms/diagnosis , Neoplasm Staging , Risk Assessment/methods , Veterans/statistics & numerical data , Aged , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy/methods , Disease-Free Survival , Female , Glottis , Humans , Laryngeal Neoplasms/epidemiology , Laryngeal Neoplasms/therapy , Male , Middle Aged , Morbidity/trends , Prognosis , Retrospective Studies , Risk Factors , Survival Rate/trends , United States/epidemiology
5.
Chem Commun (Camb) ; 52(58): 9145-8, 2016 Jul 12.
Article in English | MEDLINE | ID: mdl-27401693

ABSTRACT

We report a photocathode device consisting of GaP, a metal oxide (Al2O3 or ZnO), a phosphonate-C12-thiol monolayer, and gold nanoparticles (AuNPs). The AuNPs enhance electron transfer: in non-aqueous electrochemistry (EtV(2+) in MeCN), p-GaP|Al2O3|O3PC12S|AuNP and …ZnO|…|AuNP rescued the photocurrent (24%, 59% of Jmax-etch). Aqueous experiments (CO2 saturated KCl) using the optimized ZnO-functionalized device exhibited H(+) → H2 (FY = 66%) and CO2 → CO (FY = 6%).

6.
Magn Reson Chem ; 54(2): 126-31, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26332615

ABSTRACT

We report through-space (TS) (19)F-(19)F coupling for ortho-fluoro-substituted Z-azobenzenes. The magnitude of the TS-coupling constant ((TS) JFF ) ranged from 2.2-5.9 Hz. Using empirical formulas reported in the literature, these coupling constants correspond to non-bonded F-F distances (dFF) of 3.0-3.5 Å. These non-bonded distances are significantly smaller than those determined by X-ray crystallography or density functional theory, which argues that simple models of (19)F-(19)F TS spin-spin coupling solely based dFF are not applicable. (1)H, (13)C and (19)F data are reported for both the E and Z isomers of ten fluorinated azobenzenes. Density functional theory [B3YLP/6-311++G(d,p)] was used to calculate (19) F chemical shifts, and the calculated values deviated 0.3-10.0 ppm compared with experimental values.

7.
Am J Speech Lang Pathol ; 24(4): S974-89, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26431390

ABSTRACT

PURPOSE: We investigated the feasibility of using a virtual clinician (VC) to promote functional communication abilities of persons with aphasia (PWAs). We aimed to determine whether the quantity and quality of verbal output in dialogues with a VC would be the same or greater than those with a human clinician (HC). METHOD: Four PWAs practiced dialogues for 2 sessions each with a HC and VC. Dialogues from before and after practice were transcribed and analyzed for content. We compared measures taken before and after practice in the VC and HC conditions. RESULTS: Results were mixed. Participants either produced more verbal output with the VC or showed no difference on this measure between the VC and HC conditions. Participants also showed some improvement in postpractice narratives. CONCLUSION: Results provide support for the feasibility and applicability of virtual technology to real-life communication contexts to improve functional communication in PWAs.


Subject(s)
Aphasia, Broca/therapy , Communication , Language Therapy/methods , Neuropsychological Tests , Therapy, Computer-Assisted , User-Computer Interface , Aphasia, Broca/diagnosis , Feasibility Studies , Female , Humans , Male , Middle Aged , Narration , Practice, Psychological
SELECTION OF CITATIONS
SEARCH DETAIL
...